Hvivo PLC (LON:HVO)’s stock price traded down 1.3% on Tuesday . The company traded as low as GBX 19.80 ($0.26) and last traded at GBX 19.75 ($0.26), 2,103 shares traded hands during trading. An increase of 4,192% from the average session volume of 49 shares. The stock had previously closed at GBX 20 ($0.26).

The company has a market cap of $16.41 million and a P/E ratio of -0.93. The company has a 50 day moving average of GBX 20.19.

In other news, insider James Winschel acquired 19,753 shares of the stock in a transaction on Tuesday, July 2nd. The shares were purchased at an average price of GBX 20 ($0.26) per share, for a total transaction of £3,950.60 ($5,162.16).

About Hvivo (LON:HVO)

hVIVO plc, a specialty biopharma company, provides medical and scientific research services in the United Kingdom, the United States, and Europe. The company is developing a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases, including influenza virus, respiratory syncytial virus, asthma exacerbation, and human rhinovirus.

See Also: Systematic Risk

Receive News & Ratings for Hvivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo and related companies with MarketBeat.com's FREE daily email newsletter.